Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India · Delayed Price · Currency is INR 12.65
0.00 (0.00%)
Oct 21, 2026, 2:12 PM IST
NSE:NIDAN Revenue
In the fiscal year ending March 31, 2026, Nidan Laboratories and Healthcare had annual revenue of 255.42M INR with 4.13% growth. Nidan Laboratories and Healthcare had revenue of 124.21M in the half year ending March 31, 2026, with 0.55% growth. That makes Nidan Laboratories and Healthcare the 41,695th largest company in the world by revenue and 4,163rd in India.
Revenue
255.42M
Revenue Growth
+4.13%
P/S Ratio
0.69
Revenue / Employee
1.71M
Employees
149
Market Cap
175.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 255.42M | 10.14M | 4.13% |
| Mar 31, 2025 | 245.28M | 3.50M | 1.45% |
| Mar 31, 2024 | 241.77M | -885.00K | -0.36% |
| Mar 31, 2023 | 242.66M | -53.94M | -18.19% |
| Mar 31, 2022 | 296.60M | 88.68M | 42.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shalby | 11.76B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |
| Unihealth Hospitals | 1.32B |
| Sangani Hospitals | 1.07B |
| Vaidya Sane Ayurved Laboratories | 1.07B |
| Gaudium IVF and Women Health | 1.06B |
| Gujarat Kidney And Super Speciality | 1.01B |